Clinical Trials on Inherited Metabolic Storage Diseases in New Zealand
Total 6815 results
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
AldagenTerminatedMucopolysaccharidosis | Inborn Errors of Metabolism | Lysosomal Storage Disorders | Inherited Metabolic Diseases | Peroxisomal Storage DiseasesUnited States
-
Arcturus Therapeutics, Inc.CompletedOrnithine Transcarbamylase DeficiencyNew Zealand
-
OrsoBio, IncRecruitingInsulin ResistanceNew Zealand
-
Amicus TherapeuticsActive, not recruitingPompe DiseaseUnited States, Netherlands, United Kingdom, Australia, Germany, New Zealand
-
Christchurch Women's HospitalCompletedHyperglycaemiaNew Zealand
-
University of Auckland, New ZealandCompleted
-
Arthrosi TherapeuticsCompletedGout PatientsNew Zealand
-
Edgar National Centre for Diabetes ResearchCompletedInsulin ResistanceNew Zealand
-
Tandem Diabetes Care, Inc.Recruiting
-
North Shore Hospital, New ZealandCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Insulet CorporationCompleted
-
Zhejiang Doer Biologics Co., Ltd.RecruitingHealthy, Obesity, MetabolicallyNew Zealand
-
Diatranz Otsuka LimitedCompleted
-
University of OtagoEdgar National Centre for Diabetes ResearchCompletedObesity | Type 2 Diabetes MellitusNew Zealand
-
Christchurch Clinical Studies Trust LtdMedtronicUnknownType1diabetesNew Zealand
-
Edgar National Centre for Diabetes ResearchUniversity of OtagoUnknown
-
University of SouthamptonNational University Hospital, Singapore; Singapore Institute for Clinical Sciences and other collaboratorsCompletedHyperglycemiaSingapore, United Kingdom, New Zealand
-
Christchurch HospitalUnknownDiabetes Mellitus, Type 2New Zealand
-
Columbia UniversityWithdrawnGlycogen Storage Disease Type IIUnited States
-
Institute of Liver and Biliary Sciences, IndiaRecruitingGlycogen Storage DiseasesIndia
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe Disease Infantile-OnsetUnited States, France, South Africa
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Glycogenosis 2United States
-
Verve Therapeutics, Inc.Not yet recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Verve Therapeutics, Inc.Active, not recruitingHypercholesterolemia | Atherosclerotic Cardiovascular Disease | Heterozygous Familial HypercholesterolemiaNew Zealand, United Kingdom
-
Academy of Nutrition and DieteticsCompletedEnd Stage Renal Disease Requiring HemodialysisNew Zealand
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Genzyme, a Sanofi CompanyCompletedPompe Disease | Glycogen Storage Disease Type II (GSD II)United States, Russian Federation, United Kingdom, Bulgaria, India, Ukraine
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Amicus TherapeuticsCompletedGlycogen Storage Disease Type II | Pompe DiseaseUnited States
-
Eisai Co., Ltd.Completed
-
Liggins InstituteNovo Nordisk A/SCompleted
-
Hoffmann-La RocheCompletedEnd Stage Renal DiseaseNew Zealand
-
Genzyme, a Sanofi CompanyCompleted
-
Suzhou Alphamab Co., Ltd.Novotech (Australia) Pty LimitedCompleted
-
Genzyme, a Sanofi CompanyTerminatedGlycogenosis 2 | Glycogen Storage Disease Type II (GSD II) | Acid Maltase Deficiency | Pompe Disease (Infantile-Onset)United States, Taiwan, Germany
-
Amicus TherapeuticsRecruitingPompe DiseaseUnited States
-
University of Auckland, New ZealandHealth Research Council, New ZealandCompletedObesity | Bariatric Surgery CandidateNew Zealand
-
ShireCompletedGaucher DiseaseIndia
-
ISU Abxis Co., Ltd.CompletedGaucher DiseaseAustralia
-
MetaventionCompletedDiabetes | Endocrine, Nutritional and Metabolic Diseases (E00-E89)New Zealand
-
Genzyme, a Sanofi CompanyActive, not recruitingGlycogen Storage Disease Type II-Pompe's DiseaseUnited States, France, Japan, Taiwan, United Kingdom
-
NYU Langone HealthGenzyme, a Sanofi CompanyCompleted
-
Amicus TherapeuticsTerminatedLate-onset Pompe DiseaseUnited States, Canada, Australia, Belgium
-
Living Cell TechnologiesStatistecol Consultants LimitedCompleted
-
Living Cell TechnologiesCompletedParkinson's DiseaseNew Zealand
-
Arrowhead PharmaceuticalsCompletedDyslipidemias | Hypertriglyceridemia | Familial HypercholesterolemiaAustralia, New Zealand
-
Exsar CorporationSuspendedType I Gaucher DiseaseUnited States